Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains

Amyloid-β associated volume loss occurs only in the presence of phospho-tau

(2011) Rahul S. Desikan et al.   ANNALS OF NEUROLOGY

Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells

(2011) Xiong Zhang et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease

(2011) Yi-Fei Dong et al.   FASEB JOURNAL

The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics

(2011) Susanne M. Pritchard et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

GSK-3α/β kinases and amyloid production in vivo

(2011) Tomasz Jaworski et al.   NATURE

Post-translational modifications of tau protein: Implications for Alzheimer's disease

(2011) Ludovic Martin et al.   NEUROCHEMISTRY INTERNATIONAL

The Influence of Chronic Cerebral Hypoperfusion on Cognitive Function and Amyloid β Metabolism in APP Overexpressing Mice

(2011) Mahito Yamada et al.   PLoS One

Central Angiotensin II Stimulation Promotes β Amyloid Production in Sprague Dawley Rats

(2011) Donglin Zhu et al.   PLoS One

Vascular risk factor detection and control may prevent Alzheimer's disease

(2010) Jack C. de la Torre   AGEING RESEARCH REVIEWS

Blockade of AT1 Receptors Protects the Blood-Brain Barrier and Improves Cognition in Dahl Salt-Sensitive Hypertensive Rats

(2010) N. Pelisch et al.   AMERICAN JOURNAL OF HYPERTENSION

Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

(2010) Lars M. Ittner et al.   NATURE REVIEWS NEUROSCIENCE

Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway

(2010) Kun-Lin Chen et al.   NEUROBIOLOGY OF DISEASE

The Vascular Hypothesis of Alzheimer’s Disease: Bench to Bedside and Beyond

(2010) Jack C. de la Torre   Neurodegenerative Diseases

Protective Effects of Intranasal Losartan in the APP/PS1 Transgenic Mouse Model of Alzheimer Disease

(2010) Lusine Danielyan et al.   REJUVENATION RESEARCH

Nonhypotensive Dose of Telmisartan Attenuates Cognitive Impairment Partially Due to Peroxisome Proliferator-Activated Receptor-γ Activation in Mice With Chronic Cerebral Hypoperfusion

(2010) Kazuo Washida et al.   STROKE

Multiple reprobing of Western blots after inactivation of peroxidase activity by its substrate, hydrogen peroxide

(2009) Alexis D. Sennepin et al.   ANALYTICAL BIOCHEMISTRY

The role of GSK3 in Alzheimer disease

(2009) Félix Hernández et al.   BRAIN RESEARCH BULLETIN

The brain RAS and Alzheimer's disease

(2009) John W. Wright et al.   EXPERIMENTAL NEUROLOGY

Angiotensins in Alzheimer's disease – friend or foe?

(2009) Patrick G. Kehoe et al.   TRENDS IN NEUROSCIENCES

Angiotensins and Alzheimer's disease: a bench to bedside overview

(2009) Patrick G Kehoe   Alzheimers Research & Therapy

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

(2008) Clive Holmes et al.   LANCET